Navamedic ASA: Q3 2022 financial results
Oslo, 1 November 2022 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces its results for the third quarter of 2022. In the period, Navamedic achieved solid growth across its portfolio, resulting in a 46 per cent increase in revenues to NOK 92.8 million compared with the same quarter in 2021. Navamedic reiterates its mid- to long-term ambition of building a NOK 1 billion company.“Looking back at another successful quarter, I am pleased to see that our strategic efforts to strengthen the existing